为进一步规范药品经营环节监管行为，有效应对新业态、新模式带来的监管挑战，近日，平川区市场监督管理局组织开展以"严守经营底线，筑牢用药安 全"为主题的业务知识培训，全局99名干部职工参训。 作 者：白爱琴 核 稿：何 丹 审 核：卢昌贵 来 源：平川区市场监督管理局 白银市市场监督管理局尊重作者权益，共同维护网络知识产权。 此次培训紧扣《中华人民共和国药品管理法》《药品经营和使用质量监督管理办法》《药品网络销售监督管理办法》等法律法规要求，聚焦药品经营全链 条监管重点，从药品购进宣传、验收储存、人员管理三大模块展开系统讲解。培训内容紧贴监管实际，围绕药品经营环节人员资质审核、培训考核制度、 处方药调配规范、人员职责划分等关键内容深入解读，清晰界定企业主体责任与监管人员监督责任的边界；详细阐释供货单位资质审核标准、购销凭证留 存要求及票账货一致性检查要点；针对电商平台、直播带货等药品经营新业态，重点明确虚假宣传、夸大疗效等违规行为的甄别方法与执法尺度；同时强 调近效期药品预警机制建立与落实的重要性，全方位覆盖监管工作的重难点。 此次培训通过细化监管要点、剖析典型案例，进一步规范梳理了药品经营监管流程，明确了执法工 ...

Group 1 - The National Medical Products Administration (NMPA) held a national drug regulation work conference and "Qingyuan" action promotion meeting in Zhengzhou [1] - The meeting emphasized the need to strengthen risk assessment and firmly combat illegal and non-compliant activities [1] - The meeting also highlighted the continuation of information traceability efforts and the enhancement of comprehensive management across all varieties and the entire supply chain [1] - Additionally, the meeting called for the improvement of institutional standards to further guide and regulate drug business activities [1]

Core Viewpoint - The Urumqi Market Supervision Administration is intensifying efforts to regulate the pharmaceutical distribution sector through a "Clean Source" initiative aimed at addressing prominent issues in drug sales and ensuring drug quality safety [1][3][4] Group 1: Regulatory Actions - The administration has mobilized 127 pharmaceutical companies to adhere to principles of "strict prevention at the source, strict management during the process, and strict risk control" [3] - Key focuses include combating illegal drug sales, counterfeit drugs, and violations in online drug sales [3] - Specific measures include enhanced online inspections, strict checks on illegal procurement channels, and increased oversight of high-risk drugs [3] Group 2: Compliance and Training - The administration emphasizes the importance of compliance by requiring pharmaceutical companies to implement full product traceability and rectify identified issues [3][4] - Future plans include ongoing training for pharmacy staff to ensure comprehensive understanding of regulations, thereby safeguarding public health [4]